Table 2.
Medications and coronary intervention of the study population.
| Overall N = 135 |
Non-CAD N = 20 |
CAD N = 115 |
|
|---|---|---|---|
| Disease severity | |||
| Gensini score | 20.0 (13.0–36.0) | 7.5 (6.0–15.0) | 23.0 (16.0–39.0) |
| Disease location, % | |||
| Left main | – | – | 3 (2.6) |
| Left anterior descending | – | – | 90 (78.3) |
| Left circumflex | – | – | 50 (43.5) |
| Right coronary artery | – | – | 51 (44.3) |
| Medication, % | |||
| Antiplatelet | 130 (96.3) | 15 (75.0) | 115 (100.0) |
| Statins | 125 (92.6) | 13 (65.0) | 112 (97.4) |
| ACEI/ARB | 65 (48.1) | 8 (40.0) | 57 (49.6) |
| Intervention, % | |||
| Any intervention | 98 (72.6) | – | 98 (85.2) |
| Stent implantation | 87 (64.4) | – | 87 (75.7) |
Data shown as median (interquartile range), or number (percent) as appropriate.
ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; CAD, coronary artery disease.